{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "G",
          "alt": "A",
          "position": "53"
        },
        "variant_string_id": "SNCA G53A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The variant c.157G>A in the SNCA gene is associated with Parkinson's disease, affecting protein aggregation.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism relates to SNCA's role in neurodegeneration."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "PCR and RT-PCR were used to detect the variant and measure mRNA levels, which relate to gene expression changes.",
          "judgment": "Yes",
          "reasoning": "The assays are relevant to assessing gene expression, a factor in disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Normal controls (N.1-N.5) and patient samples were used; mRNA levels were quantified.",
          "judgment": "Partial",
          "reasoning": "Controls were used but without known pathogenic variants; replicates not explicitly detailed.",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Standard PCR and RT-PCR techniques were employed.",
          "judgment": "Yes",
          "reasoning": "Assays are standard in the field, providing valid data.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "mRNA levels in controls were 65.1-86.2% of patient's levels.",
          "judgment": "Some effect observed",
          "reasoning": "mRNA levels indicate possible functional impact without strong statistics."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The variant shows some functional impact on mRNA levels, but evidence is supported due to assay limitations."
    }
  ]
}